In addition, the deletion of C10orf90 can lead to mutations in NRAS (an oncogene) and BRAF (a proto-oncogene) [11], the latter two of which can confer greater therapeutic resistance and increased invasiveness to conjunctival melanoma [12,13]. The gene discussed is C10orf90; the disease is malignant conjunctival melanoma.